Novelix Pharmaceuticals Ltd
š Novelix Pharmaceuticals Issues 1.15M Shares via Warrant Conversion
ā¢ Allotted 1,150,000 equity shares at ā¹20 each (ā¹10 face value + ā¹10 premium)
ā¢ Shares issued upon conversion of warrants from January 10, 2025 preferential allotment
ā¢ Total subscription amount received: ā¹1.725 crore (75% of issue price)
ā¢ Major allottee: Srinidhi Fine-Chemicals LLP (1,100,000 shares)
ā¢ Individual allottee: Narahari Belide (50,000 shares)
ā¢ Paid-up equity capital increased from ā¹1.9935 crore to ā¹2.1085 crore